See more : China Hongqiao Group Limited (CHHQF) Income Statement Analysis – Financial Results
Complete financial analysis of Arvee Laboratories (India) Ltd. (ARVEE.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Arvee Laboratories (India) Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Kawaden Corporation (6648.T) Income Statement Analysis – Financial Results
- EcoSynthetix Inc. (ECO.TO) Income Statement Analysis – Financial Results
- NACL Industries Limited (NACLIND.BO) Income Statement Analysis – Financial Results
- Minnova Corp. (MCI.V) Income Statement Analysis – Financial Results
- Kubota Corporation (KUBTF) Income Statement Analysis – Financial Results
Arvee Laboratories (India) Ltd. (ARVEE.NS)
About Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 303.42M | 612.76M | 396.89M | 471.44M | 448.42M | 539.54M | 447.67M | 344.23M | 268.21M | 129.69M | 117.99M | 34.43M |
| Cost of Revenue | 261.94M | 439.67M | 258.81M | 328.45M | 323.81M | 432.04M | 343.60M | 238.44M | 169.72M | 75.87M | 75.89M | 28.68M |
| Gross Profit | 41.49M | 173.09M | 138.08M | 142.99M | 124.62M | 107.49M | 104.07M | 105.79M | 98.49M | 53.82M | 42.09M | 5.75M |
| Gross Profit Ratio | 13.67% | 28.25% | 34.79% | 30.33% | 27.79% | 19.92% | 23.25% | 30.73% | 36.72% | 41.50% | 35.68% | 16.71% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.33K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 59.29M | 14.37M | 10.54M | 27.26M | 7.36M | 6.39M | 10.51M | 1.08M | 834.00K | 588.00K | 211.00K | 151.00K |
| Selling & Marketing | 231.49K | 20.51M | 16.18M | 18.22M | 13.43M | 20.39M | 7.09M | 4.78M | 8.64M | 2.89M | 4.61M | 155.00K |
| SG&A | 59.52M | 34.88M | 26.72M | 45.48M | 20.79M | 26.78M | 17.60M | 5.86M | 9.48M | 3.48M | 4.82M | 306.00K |
| Other Expenses | 0.00 | 65.92K | 83.77K | 76.83K | 3.99K | 41.81M | 14.24K | 58.44M | 53.81M | 36.55M | 21.03M | 3.54M |
| Operating Expenses | 86.24M | 120.69M | 103.99M | 104.91M | 86.25M | 68.59M | 53.55M | 64.30M | 63.28M | 40.03M | 25.86M | 3.85M |
| Cost & Expenses | 287.99M | 560.37M | 362.80M | 433.36M | 410.05M | 500.63M | 397.15M | 302.74M | 233.00M | 115.91M | 101.75M | 32.53M |
| Interest Income | 3.58M | 2.01M | 2.65M | 2.82M | 1.40M | 3.54M | 2.28M | 2.18M | 1.02M | 690.00K | 0.00 | 939.00K |
| Interest Expense | 2.49M | 2.86M | 3.15M | 4.92M | 8.91M | 14.39M | 29.55M | 33.59M | 30.41M | 23.88M | 12.80M | 2.29M |
| Depreciation & Amortization | 15.00M | 20.81M | 23.82M | 24.68M | 23.51M | 24.12M | 21.56M | 20.69M | 14.85M | 7.26M | 2.24M | 69.00K |
| EBITDA | 35.78M | 86.34M | 61.90M | 66.86M | 64.29M | 65.90M | 70.27M | 63.03M | 49.91M | 20.90M | 18.48M | 2.89M |
| EBITDA Ratio | 11.79% | 13.97% | 15.14% | 13.73% | 13.89% | 11.98% | 15.78% | 18.35% | 18.93% | 16.25% | 11.83% | 8.39% |
| Operating Income | 14.99M | 52.02M | 29.94M | 36.62M | 37.32M | 38.24M | 50.51M | 41.49M | 35.21M | 13.79M | 16.24M | 1.91M |
| Operating Income Ratio | 4.94% | 8.49% | 7.54% | 7.77% | 8.32% | 7.09% | 11.28% | 12.05% | 13.13% | 10.63% | 13.76% | 5.54% |
| Total Other Income/Expenses | 3.31M | -95.67M | -83.67M | -208.72K | -7.46M | -13.46M | -31.36M | -32.89M | -29.86M | -23.85M | -16.01M | -1.38M |
| Income Before Tax | 18.30M | 61.65M | 34.49M | 36.41M | 30.91M | 25.44M | 19.16M | 8.60M | 5.36M | -10.06M | 232.00K | 531.00K |
| Income Before Tax Ratio | 6.03% | 10.06% | 8.69% | 7.72% | 6.89% | 4.72% | 4.28% | 2.50% | 2.00% | -7.76% | 0.20% | 1.54% |
| Income Tax Expense | 7.78M | 20.46M | 8.75M | 9.64M | 8.64M | 2.81M | 8.27M | -6.92M | 3.48M | 6.41M | 44.00K | 101.00K |
| Net Income | 10.52M | 41.19M | 25.74M | 26.77M | 22.99M | 22.63M | 10.89M | 15.52M | 1.87M | -16.47M | 188.00K | 430.00K |
| Net Income Ratio | 3.47% | 6.72% | 6.48% | 5.68% | 5.13% | 4.19% | 2.43% | 4.51% | 0.70% | -12.70% | 0.16% | 1.25% |
| EPS | 0.95 | 3.74 | 2.34 | 2.43 | 2.02 | 2.05 | 1.29 | 1.91 | 0.23 | -2.03 | 0.02 | 0.05 |
| EPS Diluted | 0.95 | 3.74 | 2.34 | 2.43 | 2.02 | 2.05 | 1.29 | 1.91 | 0.23 | -1.49 | 0.02 | 0.05 |
| Weighted Avg Shares Out | 11.07M | 11.02M | 11.02M | 11.02M | 11.02M | 11.02M | 8.43M | 8.12M | 8.12M | 8.12M | 8.12M | 8.12M |
| Weighted Avg Shares Out (Dil) | 11.02M | 11.02M | 11.02M | 11.02M | 11.02M | 11.02M | 8.43M | 11.02M | 11.02M | 11.02M | 11.02M | 11.02M |
Source: https://incomestatements.info
Category: Stock Reports